Archford Capital Strategies, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1606609 SWANSEA, IL

Position in ALNY

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$607,779

-$65,872 QoQ

Shares Held

2,019

-0.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#458

of 780 holders

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Archford Capital Strategies, LLC holds $1,967,528 across 3 Biotechnology names. ALNY ranks #3 (30.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,038	$709,397
2	REGN	Regeneron Pharmaceuticals, Inc.	1,043	$650,352
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	2,019	$607,779

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$607,779	2,019	-0.8%	Shares	Sole	2026-07-17
2026-03-31	$673,651	2,036	+0.6%	Shares	Sole	2026-04-15
2025-12-31	$804,843	2,024	0.0%	Shares	Sole	2026-01-15
2025-09-30	$922,944	2,024	+0.3%	Shares	Sole	2025-10-17
2025-06-30	$657,723	2,017	-0.1%	Shares	Sole	2025-07-17
2025-03-31	$545,170	2,019	+93.9%	Shares	Sole	2025-04-23
2022-12-31	$247,393	1,041	-0.3%	Shares	Sole	2023-01-26
2022-09-30	$208,967	1,044	—	Shares	Sole	2022-10-17
No filing history on record for this holder in this stock.